A fish declared extinct in the wild is being successfully reintroduced to its habitat. The Tequila fish, was 'missing' from the wild since 2003. But now, more than 1500 Tequila fish have been released in the wild in Southwest Mexico and their numbers are increasing.

The fish were grown in a joint effort between the UK and Michoacana University in Mexico. The decades-long effort has born fruit now.

The project started in 1998 when scientists at the university received five pairs of fish from Chester Zoo. These fish were carefully kept in university's labs. Over the years, these fish founded a colony. The scientists carefully grew these fish by providing them required nutrition and conditions.

However, it is often seen that animals bred in captivity cannot survive in the wild as there are factors like predators, competition for food, adverse environmental conditions that limit their growth. Hence, 'training' is needed.

When the colony of Tequila fish grew to have 40 pairs in lab, scientists introduced them to an artificial pond for their 'training'. Here, the fish were subjected naturally to factors they did not encounter in the lab. The fish flourished in the artificial pond and the numbers increased to 10,000. This indicated that they were coping well to conditions.

It was then the scientists decided to reintroduce the fish in the wild.

Reintroduction of the Tequila fish can become a model for freshwater species that are currently under threat. 
&nbsp;

A fish declared extinct in the wild is being successfully reintroduced to its habitat. The Tequila fish, was 'missing' from the wild since 2003. But now, more than 1500 Tequila fish have been released in the wild in Southwest Mexico and their numbers are increasing.

A fish declared extinct in the wild is being successfully reintroduced to its habitat. The Tequila fish, was 'missing' from the wild since 2003. But now, more than 1500 Tequila fish have been released in the wild in Southwest Mexico and their numbers are increasing. The fish were grown in a joint effort between the UK and Michoacana University in Mexico. The decades-long effort has born fruit now. The project started in 1998 when scientists at the university received five pairs of fish from Chester Zoo. These fish were carefully kept in university's labs. Over the years, these fish founded a colony. The scientists carefully grew these fish by providing them required nutrition and conditions. However, it is often seen that animals bred in captivity cannot survive in the wild as there are factors like predators, competition for food, adverse environmental conditions that limit their growth. Hence, 'training' is needed. When the colony of Tequila fish grew to have 40 pairs in lab, scientists introduced them to an artificial pond for their 'training'. Here, the fish were subjected naturally to factors they did not encounter in the lab. The fish flourished in the artificial pond and the numbers increased to 10,000. This indicated that they were coping well to conditions. It was then the scientists decided to reintroduce the fish in the wild. Reintroduction of the Tequila fish can become a model for freshwater species that are currently under threat.

Researchers design 'flying saucer' that can levitate on moon, asteroids

The University of California will soon be granted a potentially valuable patent on the revolutionary gene-editing technology known as CRISPR, according to a document filed by the US patent office on Friday.

The US Patent and Trademark Office decision to grant the patent could further fuel a long-running rivalry between the university and the Broad Institute, a biological and genomic research centre affiliated with the Massachusetts Institute of Technology (MIT) and Harvard University that also holds patents on CRISPR.

Patent rights to CRISPR could eventually be worth billions of dollars because the technology could revolutionize the treatment of diseases, crop engineering, and other areas.

The so-called notice of allowance from the Patent and Trademark Office means the patent will likely be issued within eight weeks. Once issued, it could still face challenges in administrative or court proceedings.

"The issued patent will encompass the use of CRISPR-Cas9 technology in any cellular or non-cellular environment", Eldora Ellison, a lead patent strategist on CRISPR matters for the University of California, said in an online statement.

CRISPR works as molecular scissors that can trim away unwanted pieces of genetic material and replace them with new ones. Easier to use than older techniques, it has quickly become a preferred method of gene editing in research labs.

The patent being approved stems from an application filed by microbiologists Jennifer Doudna of the University of California at Berkeley and Emmanuelle Charpentier of the University of Vienna in 2012. The scientists filed the application, the first ever for a CRISPR-related patent after they discovered how CRISPR could be used to edit genomes in simple pieces of DNA called plasmids.

A team at the Broad Institute led by bioengineer Feng Zhang applied for their own patent months later but paid for a fast-track review process, which landed them the first CRISPR patent in 2014. The Broad's patents covered CRISPR's use in so-called eukaryotic cells, which include animal and human cells.

The new patent decision "does not affect the CRISPR patent estate held by Broad, MIT, and Harvard in any way," Broad Institute spokesman David Cameron said in a statement.

In April 2015, the University of California filed a petition with the Patent and Trademark Office challenging the Broad Institute's patents, claiming they covered the same thing as the university's earlier application.

However, the board rejected that petition, allowing both the University of California's application and the Broad Institute patents to stand. Its decision was upheld by a federal appeals court last year.

Both institutions have licensed their CRISPR intellectual property to biotech companies.

The University of California will soon be granted a potentially valuable patent on the revolutionary gene-editing technology known as CRISPR, according to a document filed by the US patent office on Friday.

The University of California will soon be granted a potentially valuable patent on the revolutionary gene-editing technology known as CRISPR, according to a document filed by the US patent office on Friday. The US Patent and Trademark Office decision to grant the patent could further fuel a long-running rivalry between the university and the Broad Institute, a biological and genomic research centre affiliated with the Massachusetts Institute of Technology (MIT) and Harvard University that also holds patents on CRISPR. Patent rights to CRISPR could eventually be worth billions of dollars because the technology could revolutionize the treatment of diseases, crop engineering, and other areas. The so-called notice of allowance from the Patent and Trademark Office means the patent will likely be issued within eight weeks. Once issued, it could still face challenges in administrative or court proceedings. "The issued patent will encompass the use of CRISPR-Cas9 technology in any cellular or non-cellular environment", Eldora Ellison, a lead patent strategist on CRISPR matters for the University of California, said in an online statement. CRISPR works as molecular scissors that can trim away unwanted pieces of genetic material and replace them with new ones. Easier to use than older techniques, it has quickly become a preferred method of gene editing in research labs. The patent being approved stems from an application filed by microbiologists Jennifer Doudna of the University of California at Berkeley and Emmanuelle Charpentier of the University of Vienna in 2012. The scientists filed the application, the first ever for a CRISPR-related patent after they discovered how CRISPR could be used to edit genomes in simple pieces of DNA called plasmids. A team at the Broad Institute led by bioengineer Feng Zhang applied for their own patent months later but paid for a fast-track review process, which landed them the first CRISPR patent in 2014. The Broad's patents covered CRISPR's use in so-called eukaryotic cells, which include animal and human cells. The new patent decision "does not affect the CRISPR patent estate held by Broad, MIT, and Harvard in any way," Broad Institute spokesman David Cameron said in a statement. In April 2015, the University of California filed a petition with the Patent and Trademark Office challenging the Broad Institute's patents, claiming they covered the same thing as the university's earlier application. However, the board rejected that petition, allowing both the University of California's application and the Broad Institute patents to stand. Its decision was upheld by a federal appeals court last year. Both institutions have licensed their CRISPR intellectual property to biotech companies.

University of California to be granted pioneering CRISPR patent

massachusetts-institute-of-technology

Massachusetts Institute Of Technology, News on Massachusetts Institute Of Technology, stories on Massachusetts Institute Of Technology, articles on Massachusetts Institute Of Technology, Massachusetts Institute Of Technology stories at Wion, Massachusetts Institute Of Technology news, Massachusetts Institute Of Technology latest news

massachusetts institute-of-technology

Researchers design 'flying saucer' that can levitate on moon, asteroids

University of California to be granted pioneering CRISPR patent